Advertisement
UK markets close in 1 hour 41 minutes

  • FTSE 100

    8,055.73
    +15.35 (+0.19%)
     

  • FTSE 250

    19,586.21
    -133.16 (-0.68%)
     

  • AIM

    753.30
    -1.39 (-0.18%)
     

  • GBP/EUR

    1.1662
    +0.0017 (+0.15%)
     

  • GBP/USD

    1.2471
    +0.0008 (+0.07%)
     

  • Bitcoin GBP

    50,785.39
    -2,195.09 (-4.14%)
     

  • CMC Crypto 200

    1,364.57
    -18.01 (-1.30%)
     

  • S&P 500

    5,001.11
    -70.52 (-1.39%)
     

  • DOW

    37,862.63
    -598.29 (-1.56%)
     

  • CRUDE OIL

    82.66
    -0.15 (-0.18%)
     

  • GOLD FUTURES

    2,332.80
    -5.60 (-0.24%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,845.17
    -243.53 (-1.35%)
     

  • CAC 40

    7,971.17
    -120.69 (-1.49%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Pfizer India Ltd. :500680-IN: Earnings Analysis: Q3, 2017 By the Numbers : February 3, 2017

CapitalCube
Updated
Pfizer India Ltd. :500680-IN: Earnings Analysis: Q3, 2017 By the Numbers : February 3, 2017

Categories: Yahoo Finance Get free summary analysis Pfizer India Ltd. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of INR 4,846.60 million, Net Earnings of INR 623.70 million. Gross margins narrowed from 37.08% to 36.72% compared to the same period last year, operating (EBITDA) margins now 11.44% from 15.28%. Earnings growth due ... Read more (Read more...)

Continue reading